Myriad shareholders approve 6.5M share increase to 2017 equity plan; per-participant cap raised

MYRIAD GENETICS INC

Stockholders approved amendment to 2017 Plan adding 6.5 million shares for equity grants.
Board increased annual per-participant share cap from 500,000 to 574,040 shares.
All three director nominees (Raha, Dreismann, Reitan) elected with >97% of votes cast.
Advisory say-on-pay approved with 92% of votes cast in favor.
Ernst & Young ratified as auditor for fiscal 2025 with 95.6% support.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.